Ana Belèn R. B.
- Country
- Spain
- Department
- Oncología
Research Overview
Data & Insights
Has run more than one trial at 0 of 11 partner sites.
Specializations
Pancreatic Cancer Research
This investigator specializes in developing innovative treatment approaches for metastatic pancreatic ductal adenocarcinoma (mPDAC), with particular focus on combination therapy strategies.
- Advanced Pancreatic Cancer Treatment
- Combination Therapy Development
- First-line Treatment Optimization
The research explores therapeutic applications combining established medications to enhance treatment efficacy for pancreatic cancer patients.
Drug Repurposing Studies
The investigator focuses on investigating the potential of repurposed medications in cancer treatment, specifically examining established drugs in new therapeutic combinations.
- Novel Drug Combinations
- Treatment Enhancement Strategies
- Therapeutic Innovation
Their work involves evaluating how existing medications can be utilized in new ways to improve cancer treatment outcomes.
Clinical Therapeutics
Expertise in developing multi-drug treatment regimens for advanced cancer care, with emphasis on improving standard treatment protocols.
- Treatment Protocol Development
- Clinical Efficacy Studies
- Advanced Cancer Care
The research focuses on enhancing therapeutic effectiveness through innovative medication combinations in oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.